P609: CLINICOBIOLOGICAL CHARACTERISTICS AND TREATMENT EFFICACY OF NOVEL AGENTS IN CHRONIC LYMPHOCYTIC LEUKEMIA WITH IGLV3-21R110. (23rd June 2022) - Hengeveld, P.; Ertem, Y. E.; Dubois, J.; Mellink, C.; van der Kevie-Kersemaekers, A.-M.; Evers, L.; Heezen, K.; Kolijn, P. M.; Mook, O.; Motazacker, M. M.; Nasserinejad, K.; Kersting, S.; et al.